Description
Beta-2-glycoprotein is a protein that possesses pronounced anticoagulant activity. This test is intended for the quantitative determination of antibodies to beta-2-glycoprotein (IgM) in blood serum and is used in the diagnosis of antiphospholipid syndrome (APS) and/or in the assessment of thrombotic risk in patients with systemic lupus erythematosus (SLE).
Period of execution
Within 9 days. The specified time does not include the day of biomaterial collection
Biomaterial type